​

Spero Therapeutics (SPRO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Spero Therapeutics Revenue Highlights

Latest Revenue (Y)

$47.98M

Latest Revenue (Q)

$13.47M

Main Segment (Y)

Collaboration Revenue Related Party

Spero Therapeutics Revenue by Period

Spero Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$47.98M-50.40%
2023-12-31$96.73M99.13%
2022-12-31$48.58M166.10%
2021-12-31$18.26M95.67%
2020-12-31$9.33M96.75%
2019-12-31$4.74M19.57%
2018-12-31$3.97M100.40%
2017-12-31$1.98M490.75%
2016-12-31$335.00K100.00%
2015-12-31--

Spero Therapeutics generated $47.98M in revenue during NA 2024, up -50.40% compared to the previous quarter, and up 1011.75% compared to the same period a year ago.

Spero Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$13.47M123.85%
2024-06-30$6.02M43.13%
2024-03-31$4.20M-94.15%
2023-12-31$71.83M181.97%
2023-09-30$25.47M3132.61%
2023-06-30$788.00K6.49%
2023-03-31$740.00K-98.40%
2022-12-31$46.30M4179.26%
2022-09-30$1.08M20.76%
2022-06-30$896.00K262.75%
2022-03-31$247.00K-91.00%
2021-12-31$2.74M-10.44%
2021-09-30$3.06M-40.48%
2021-06-30$5.15M-29.48%
2021-03-31$7.30M282.80%
2020-12-31$1.91M-52.27%
2020-09-30$4.00M131.33%
2020-06-30$1.73M921.89%
2020-03-31$169.00K-75.72%
2019-12-31$696.00K304.65%
2019-09-30$172.00K-92.02%
2019-06-30$2.16M-43.37%
2019-03-31$3.81M125.00%
2018-12-31$1.69M157.14%
2018-09-30$658.00K42.12%
2018-06-30$463.00K-59.84%
2018-03-31$1.15M16.11%
2017-12-31$993.00K66.33%
2017-09-30$597.00K139.76%
2017-06-30$249.00K77.86%
2017-03-31$140.00K-58.21%
2016-12-31$335.00K100.00%
2016-09-30--

Spero Therapeutics generated $13.47M in revenue during Q3 2024, up 123.85% compared to the previous quarter, and up 1709.26% compared to the same period a year ago.

Spero Therapeutics Revenue Breakdown

Spero Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Collaboration Revenue Related Party$27.02M
Collaboration Revenue$371.00K
Grant Revenue$20.58M

Spero Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Collaboration Revenue Related Party (56.33%), Grant Revenue (42.90%), and Collaboration Revenue (0.77%).

Spero Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$138.10M$33.43M
SPROSpero Therapeutics$47.98M$13.47M
NUVBNuvation Bio$7.87M$727.00K
ACHLAchilles Therapeutics--
NXTCNextCure--
TILInstil Bio--
ASMBAssembly Biosciences-$6.84M

SPRO Revenue FAQ

What is Spero Therapeutics’s yearly revenue?

Spero Therapeutics's yearly revenue for 2024 was $47.98M, representing a decrease of -50.40% compared to 2023. The company's yearly revenue for 2023 was $96.74M, representing an increase of 99.13% compared to 2022. SPRO's yearly revenue for 2022 was $48.58M, representing an increase of 166.10% compared to 2021.

What is Spero Therapeutics’s quarterly revenue?

Spero Therapeutics's quarterly revenue for Q3 2024 was $13.47M, a 123.85% increase from the previous quarter (Q2 2024), and a -47.12% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $6.02M, a 43.13% increase from the previous quarter (Q1 2024), and a 663.58% increase year-over-year (Q2 2023). SPRO's quarterly revenue for Q1 2024 was $4.2M, a -94.15% decrease from the previous quarter (Q4 2023), and a 468.11% increase year-over-year (Q1 2023).

What is Spero Therapeutics’s revenue growth rate?

Spero Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -1.24%, and for the last 5 years (2020-2024) was 414.22%.

What are Spero Therapeutics’s revenue streams?

Spero Therapeutics's revenue streams in c 24 are Collaboration Revenue Related Party, Collaboration Revenue, and Grant Revenue. Collaboration Revenue Related Party generated $27.02M in revenue, accounting 56.33% of the company's total revenue Collaboration Revenue generated $371K in revenue, accounting 0.77% of the company's total revenue Grant Revenue generated $20.58M in revenue, accounting 42.90% of the company's total revenue

What is Spero Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Spero Therapeutics was Collaboration Revenue Related Party. This segment made a revenue of $27.02M, representing 56.33% of the company's total revenue.